Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Neoplasms of the CNS

Free Subscription 18.08.2025 1 Acta Neuropathol 1 Cancer 1 Clin Cancer Res 1 J Clin Oncol 7 J Neurooncol 1 J Neuropathol Exp Neurol 1 Neuro Oncol 1 Neurol Res 1 Neuroradiology 1 Neurosurgery 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. MIKKELSEN MK, Li X, Yu K, High AA, et al
   Diffuse leptomeningeal glioneuronal tumor (DLGNT): a comprehensive clinical and molecular analysis.
   Acta Neuropathol. 2025;150:18.
   PubMed         Abstract available
   
   

   
   Cancer

2. RHA SY, Castanon E, Gill S, Senellart H, et al
   Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP-005 study recurrent glioblastoma cohort.
   Cancer. 2025;131:e70015.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

3. VOLOVETZ J, Buchwald LV, Straede K, Kjaer A, et al
   The importance of integrating surgical resection into preclinical glioblastoma modeling.
   Clin Cancer Res. 2025 Aug 11. doi: 10.1158/1078-0432.CCR-25-0788.
   PubMed         Abstract available
   
   

   
   J Clin Oncol

4. COOPER BT, Kondziolka D
   Modern Targeted Radiation in Patients With Brain Metastases From Small Cell Lung Cancer.
   J Clin Oncol. 2025 Aug 12:JCO2501259. doi: 10.1200/JCO-25-01259.
   PubMed        
   
   

   
   J Neurooncol

5. NISHIWAKI T, Kudo U, Nakamura S, Kuse Y, et al
   Synergistic antitumor and radiosensitizing effects of alpha-sulfoquinovosyl-acylpropanediol (SQAP) via PI3K/Akt inhibition and DNA repair impairment in glioblastoma.
   J Neurooncol. 2025 Aug 11. doi: 10.1007/s11060-025-05194.
   PubMed         Abstract available
   
   
6. BRASCHI EL, Trumble O, Casper A, Amdur RJ, et al
   Pattern of recurrence with 1.0 cm CTV in brain glioblastoma treated with radiotherapy.
   J Neurooncol. 2025 Aug 11. doi: 10.1007/s11060-025-05195.
   PubMed         Abstract available
   
   
7. RAMIREZ FERRER E, Zuluaga-Garcia JP, Alzate JD, Mayorga-Corvacho J, et al
   Impact of healthcare disparities on the treatment and survival of patients with high-grade gliomas in Colombia: a multicenter inverse probability-weighted cohort analysis.
   J Neurooncol. 2025 Aug 12. doi: 10.1007/s11060-025-05198.
   PubMed         Abstract available
   
   
8. MAO M, Li Z, Zheng W, Xia H, et al
   Collagen type I alpha 1 induces radio-resistance in hypoxic glioblastoma cells by promoting autophagy.
   J Neurooncol. 2025 Aug 12. doi: 10.1007/s11060-025-05132.
   PubMed         Abstract available
   
   
9. SUN MZ, Contreras E, Treger J, Imbroane M, et al
   Immunotherapeutic targeting of NY-ESO-1 in malignant meningiomas with TCR-transduced T-cells.
   J Neurooncol. 2025 Aug 13. doi: 10.1007/s11060-025-05200.
   PubMed         Abstract available
   
   
10. NEU M, Shiban E, Krauss P, Sommer B, et al
    Comparing intraoperative radiotherapy (IORT) and hypofractionated stereotactic radiotherapy (HSRT) after brain metastasis surgery: impact on oncological outcome and radionecrosis.
    J Neurooncol. 2025 Aug 13. doi: 10.1007/s11060-025-05152.
    PubMed         Abstract available
    
    
11. PENG TC, Hsieh MH, Lin CF, Kuan AS, et al
    Repeated stereotactic radiosurgery for high grade meningioma.
    J Neurooncol. 2025 Aug 13. doi: 10.1007/s11060-025-05165.
    PubMed         Abstract available
    
    

    
    J Neuropathol Exp Neurol

12. ZHANG Z, Guo X, Qi T, Wang C, et al
    METTL14/IGF2BP2-mediated m6A modification of PD-L1 promotes proliferation, metastasis, and immune escape in high-grade gliomas.
    J Neuropathol Exp Neurol. 2025 Aug 11:nlaf090. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

13. PELLERINO A, Priego N, Bertero L, Ricci AA, et al
    STAT3 expression in brain metastases from breast cancer is correlated with molecular subtype and impacts clinical outcome.
    Neuro Oncol. 2025 Aug 9:noaf187. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neurol Res

14. CHEN S, Liu Z, Gao Y
    FAM111B as a biomarker influences the prognosis and immune microenvironment of low-grade gliomas.
    Neurol Res. 2025 Aug 10:1-18. doi: 10.1080/01616412.2025.2538129.
    PubMed         Abstract available
    
    

    
    Neuroradiology

15. KUNDAL K, Rao KV, Dhanda SK, Kumar N, et al
    Tumor location, genomic alterations, and radiomic features as predictors of survival in glioblastoma: a Multi-Modal analysis.
    Neuroradiology. 2025 Aug 12. doi: 10.1007/s00234-025-03742.
    PubMed         Abstract available
    
    

    
    Neurosurgery

16. LI HY, Lao IH, Chen YC, Wu YY, et al
    Impact of Subventricular Zone Invasion on Preoperative Cognitive Decline in Patients with Diffuse Glioma.
    Neurosurgery. 2025 Aug 11. doi: 10.1227/neu.0000000000003676.
    PubMed         Abstract available
    
    

    
    PLoS One

17. 
    Retraction: Suppression of uPA and uPAR Attenuates Angiogenin Mediated Angiogenesis in Endothelial and Glioblastoma Cell Lines.
    PLoS One. 2025;20:e0330088.
    PubMed        
    
    
18. REN Y, Lu D, Wang F, Wang Z, et al
    A multi-omics atlas of CAF subtypes reveals apCAF-M2 macrophage interactions driving immune resistance in glioma.
    PLoS One. 2025;20:e0329801.
    PubMed         Abstract available
    
    
19. MEHRPOUYA Z, Khatibi T, Sedighipashaki A
    Enhancing meningioma tumor classification accuracy through multi-task learning approach and image analysis of MRI images.
    PLoS One. 2025;20:e0327782.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.